Archives
-
Epinephrine in Local Anesthesia: Concentration and Risk
2026-09-07
Cassidy, Phero, and Grau’s review explains how vasoconstrictors improve local-anesthetic duration, hemostasis, and neural blockade while also producing dose- and route-dependent systemic effects. Its central practical conclusion is that 1:200,000 epinephrine can often provide effective anesthesia with less unnecessary adrenergic exposure than stronger concentrations.
-
Naloxone Hydrochloride: A Causal Probe
2026-09-05
Naloxone hydrochloride is more than an emergency antagonist: it is a reversible probe for separating opioid receptor signaling from receptor-independent biology. This article connects withdrawal-anxiety circuitry, neural stem cell proliferation modulation, and assay design while highlighting how to interpret antagonist data responsibly.
-
PEDV Hijacks IMPDH-Dependent Nucleotide Biosynthesis
2026-09-04
Zhou and colleagues identify IMPDH2 and guanine nucleotide biosynthesis as host dependencies for porcine epidemic diarrhea virus (PEDV) replication. By combining comparative metabolomics, IMPDH2 knockdown, and merimepodib inhibition, the study provides a mechanistic basis for host-directed antiviral research while highlighting cell-type-specific metabolic responses.
-
Acetoacetic Acid Sodium Salt: Assay Workflows
2026-09-04
Build reproducible ketone-body experiments with a water-compatible sodium acetoacetate source, from stock preparation through metabolic readouts. Practical dosing, matrix controls, and orthogonal QC help distinguish true energy-metabolism effects from solubility, pH, or handling artifacts.
-
PDK4 Inhibitors: Findings from an Anthraquinone Series
2026-09-03
The reference study used anthraquinone hit optimization to identify compound 8c, an allosteric PDK4 inhibitor with strong biochemical activity and encouraging metabolic, allergic-disease, and anticancer findings. Its combination of enzyme assays, pharmacokinetic evaluation, mouse models, and docking provides a useful preclinical framework for developing PDK4-directed therapies, while leaving important questions about selectivity, durability, and clinical translation unresolved.
-
G007-LK Tankyrase 1/2 Inhibitor Guide
2026-09-03
G007-LK is a selective tankyrase 1/2 inhibitor for mechanistic studies of Wnt/β-catenin signaling, β-catenin turnover, and cancer biology. Its reported nanomolar biochemical activity and preclinical activity in APC-mutant colorectal and hepatocellular carcinoma models support use as a research tool, not as evidence of clinical efficacy.
-
Fumagillin Against Azumiobodo hoyamushi
2026-09-02
The reference study compared 20 antiprotozoal, antimicrobial, oxidizing, and halogen-based compounds against Azumiobodo hoyamushi, identifying Fumagillin as a moderately active agent in vitro rather than one of the most potent treatments. Its paired in vitro–in vivo design showed that formalin and chlorine dioxide reduced parasite burdens in experimentally infected ascidians, providing a practical framework for evaluating disinfection strategies in aquaculture.
-
(Z)-4-Hydroxytamoxifen in ER Research
2026-09-02
Use (Z)-4-Hydroxytamoxifen to build high-affinity estrogen receptor assays, compare antiestrogenic responses, and separate ER biology from relapse-associated tumor heterogeneity. This practical guide connects formulation, concentration-response design, prolactin assays, and proliferation-tracing models while emphasizing controls that prevent solvent and receptor-status artifacts.
-
ABT-263 (Navitoclax) in Apoptosis Research
2026-09-01
ABT-263, also called Navitoclax, is an orally bioavailable BH3 mimetic that inhibits Bcl-2, Bcl-xL, and Bcl-w. Its research value is greatest when mitochondrial apoptotic priming, MCL1 expression, and orthogonal cell-death readouts are interpreted together.
-
Caged Bioluminescent Probe for the Immunoproteasome
2026-09-01
Loy and Trader present a protocol for synthesizing and applying a cleavable, immunoproteasome-selective bioluminescent probe that reports catalytic activity through a plate-reader assay. The workflow addresses limitations of fluorescent and technically demanding probes while providing a platform for live-cell studies and future tissue or in vivo imaging validation.
-
Norepinephrine Formulations in Critical Care Research
2026-08-31
This position paper identifies a clinically important source of inconsistency: norepinephrine may be labeled and reported as either a conjugated salt or norepinephrine base. Its central contribution is a practical framework for formulation-aware dosing, trial enrollment, dataset harmonization, and safer global reporting.
-
Resveratrol, Smad Signaling, and GBM EMT
2026-08-31
The reference study shows that resveratrol suppresses TGF-β1-induced epithelial–mesenchymal transition, migration, invasion, and stem-like behavior in glioblastoma models through Smad-dependent signaling. Its combination of molecular, cellular, and xenograft assays provides a useful framework for studying how TGF-β pathway modulation may influence GBM recurrence-associated phenotypes.
-
GSK-923295: CENP-E Inhibitor for Mitosis
2026-08-30
GSK-923295 is a small-molecule CENP-E inhibitor that suppresses CENP-E ATPase activity and produces mitotic arrest. Product-dossier data report nanomolar biochemical potency, broad tumor-cell growth inhibition, and preclinical antitumor activity in Colo205 colon cancer xenografts.
-
SB203580 Workflows for p38 MAPK Research
2026-08-29
Build cleaner p38 MAPK experiments with SB203580 by separating kinase inhibition from phosphorylation-state measurements. This practical guide covers solution preparation, assay timing, pathway selectivity, neuroprotection studies, multidrug resistance reversal, and troubleshooting.
-
Indomethacin A8449: Practical Assay Workflow
2026-08-28
Indomethacin (SKU A8449) provides a controlled pharmacological perturbation for COX-oriented inflammation research and exploratory PPAR or membrane studies. It is appropriate for solvent-matched biochemical and cell-based workflows, but its dossier IC50 values should not be treated as universal cellular doses, clinical guidance, or proof of a membrane-signaling mechanism.